# The Effects of Glucagon on Hepatic Metabolism

> **NCT05500586** · PHASE1,PHASE2 · COMPLETED · sponsor: **Adrian Vella** · enrollment: 21 (actual)

## Conditions studied

- Obesity
- Type2diabetes
- NAFLD

## Interventions

- **DRUG:** Glucagon response study

## Key facts

- **NCT ID:** NCT05500586
- **Lead sponsor:** Adrian Vella
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-20
- **Primary completion:** 2025-09-30
- **Final completion:** 2026-03-31
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05500586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05500586, "The Effects of Glucagon on Hepatic Metabolism". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05500586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*